ACR-997 (n=14) | SLICC-2012 (n=30) | EULAR/ACR-2019 (n=33) | SLERPI (n=41) | |
Primary Sjogren’s syndrome | 4 (28.6) | 9 (30.0) | 8 (24.2) | 15 (36.6) |
Undifferentiated connective tissue disease | 4 (28.6) | 7 (23.3) | 7 (21.2) | 9 (22.0) |
Rheumatoid arthritis | 1 (7.1) | 3 (10.0) | 10 (30.3) | 5 (12.2) |
Idiopathic inflammatory myopathies | 4 (28.6) | 3 (10.0) | 3 (9.1) | 4 (9.8) |
Systemic sclerosis | 0 | 3 (10.0) | 2 (6.1) | 3 (7.3) |
Mixed connective tissue disease | 1 (7.1) | 2 (6.7) | 2 (6.1) | 2 (4.9) |
Primary systemic vasculitis | 0 | 1 (3.3) | 0 | 1 (2.4) |
Behcet’s disease | 0 | 2 (6.7) | 1 (3.0) | 0 |
Pneumonia | 0 | 0 | 0 | 2 (4.9) |
Values are n (%).
ACR, American College of Rheumatology; EULAR, European League Against Rheumatism; SLERPI, Systemic Lupus Erythematosus Risk Probability Index; SLICC, Systemic Lupus International Collaborating Clinics.